Biotech firm GRAIL to invest $103M for Durham facility, adding hundreds of jobs
Date Published:
DURHAM — Biotech firm GRAIL, headquartered in Menlo Park, California, has promised to invest at least $103 million to build…
Ashley Warren
California firm eyeing cancer detection picks RTP for $100 million investment, 400 jobs
Date Published:
A health care company with a focus on the early detection of cancer plans a $100 million investment in Research…
BioCryst hauls in $115 million from public offering
Date Published:
After announcing an expected $100 million in gross proceeds from its latest pubic offering, a Triangle drugmaker says it added…
Despite pandemic, developers press forward with massive Chatham Park project
Date Published:
After some bumps in the road brought on by the Covid-19 pandemic, the developers behind the massive Chatham Park and…
Raleigh biotech firm Agile Sciences raises $1M in equity
Date Published:
RALEIGH — Raleigh biopharmaceutical company Agile Sciences, which is pioneering a new mechanistic approach for the treatment of antibiotic-resistant, life-threatening…
Eli Lilly starts first human trial for Covid-19 antibody therapy
Date Published:
Eli Lilly and Company said Monday it has started the first human trial of an antibody therapy designed to treat…
Raleigh-based Icagen lands potential $274M+ development deal with Roche
Date Published:
RALEIGH – Icagen, the Raleigh-based firm focused on small molecule research with the potential for use in new drugs, has…
Pandemic means challenges, opportunities for RTP’s entrepreneurial ecosystem
Date Published:
RESEARCH TRIANGLE PARK – The COVID-19 pandemic has brought more attention than ever to life science research and development as…
Research funding flows into Triangle as pandemic drags on
Date Published:
The Covid-19 pandemic has disrupted most industries across the world and led to unprecedented economic fallout threatening many revenue streams.…